Airway ManagementNCT06602830
I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery
An observational study of Airway Management and Supraglottic Airway, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.
Trial summary
i-gel Plus is a novel supraglottic airway device (SGA). Feasibility of second-generation SGAs in patients undergoing elective laparoscopic surgery has been demonstrated in various studies. Read more about this study
- Who is it for?
- Ages 18 to 89 years
- Conditions the study is for
- Airway Management, Supraglottic Airway, General Anesthesia
- How many people
- 48 participants
- Where
- 1 siteGermany
- Study dates
- 1 Oct 2024to 3 Feb 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 89 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients undergoing elective laparoscopic surgery with i-gel Plus used for airway management
Who may be able to join
- Patients scheduling for elective laparoscopic surgery
- Planned airway management using a SGA
- Adult patients (age 18-89 years)
- ASA physical status 1-3
Who cannot join
- Pregnant or breastfeeding women
- Non-fasted patients
- Increased risk of aspiration or other contraindications for supraglottic mask ventilation
- Body mass index (BMI) >35 kg/m2
- Inability to understand or sign informed consent
Trial locations and contacts
1 site in 1 country.
Germany1 site
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, 20246
About this study
Official title: I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery -a Prospective Observational Study-
i-gel Plus is a novel supraglottic airway device (SGA). Feasibility of second-generation SGAs in patients undergoing elective laparoscopic surgery has been demonstrated in various studies. During laparoscopic surgery intrabdominal pressure is increased by capnoperitoneum and frequently minute ventilation has to be adopted to counteract hypercapnia, and higher inspiratory peak pressures have to be expected. It is uncertain, however, if the i-gel Plus facilitates appropriate ventilation with low leakage volumes in patients undergoing laparoscopic surgery.
The primary aim of this single-center non-inferiority study is to assess the leak fraction of the i-gel Plus under conditions of capnoperitoneum (with and without Trendelenburg position) and to compare it with baseline conditions. Secondary aims are to assess secondary outcome parameters during capnoperitoneum (with and without Trendelenburg position) and to compare them with baseline conditions.
- Keywords
- Airwaymanagement, Laparoscopic surgery, Capnoperitoneum
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients undergoing laparoscopic surgery | Measurement of primary and secondary outcome parameters at different time points during the procedure. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Leak fraction
Ventilation parameter - volume per tidal volume
Measured: 3 houres
Secondary outcomes (19)
Oropharyngeal seal pressure [cm H2O]
Clinical assessment - leak pressure with audible leak
Measured: 3 houres
Leakage volume (ml)
Ventilation parameter - as displayed on the ventilator
Measured: 3 houres
Tidal volume (ml)
Ventilation parameter - as displayed on the ventilator
Measured: 3 houres
Inspiratory peak pressure (cm H2O)
Ventilation parameter - as displayed on the ventilator
Measured: 3 houres
Positive endexpiratory pressure (PEEP) (cm H2O)
Ventilation parameter - as displayed on the ventilator
Measured: 3 houres
Intraabdominal pressure under capnoperitoneum [mmHg]
Measured intraoperativ under capnoperitoneum [mmHg]
Measured: 3 houres
Respiratory rate (1/min)
Ventilation parameter - as displayed on the ventilator
Measured: 3 houres
Minute ventilation (l/min/kg)
Ventilation parameter - as displayed on the ventilator
Measured: 3 houres
Endtidal CO2 [mmHg]
Ventilation parameter - as displayed on the ventilator
Measured: 3 houres
Number of insertion attempts
Clinical assessment - SGA insertion attempts
Measured: 3 houres
Insertion success rate (%)
Clinical assessment
Measured: 3 houres
First-attempt insertion success rate (%)
Clinical assessment - successful placement in only one insertion attempt
Measured: 3 houres
Necessity of adjustment maneuvers during the procedure
Clinical assessment
Measured: 3 houres
Insertion time (sec)
Clinical assessment
Measured: 3 houres
Lowest oxygen saturation (%)
Measured by pulse oximetry
Measured: 3 houres
Difficulty of insertion
Clinical assessment on a scale between 1-5
Measured: 3 houres
Ease of gastric tube insertion
Clinical assessment - rating on a scale from 1-5
Measured: 3 houres
Postoperative complications
Clinical assessment
Measured: 24 hours postoperatively
Complications at the end of surgery
Clinical assessment
Measured: 3 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start1 Oct 2024
- Primary completion3 Feb 2025
- Study completion3 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Airway ManagementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 48 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Martin Petzoldt, MD, Principal investigator, Universitätsklinikum Hamburg-Eppendorf
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06602830
- Sponsor's protocol ID
- 2024-101346-BO-ff
- Status last verified
- Jun 2025
- First submitted
- 16 Sep 2024
- Last updated
- 8 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery -a Prospective Observational Study-
- ClinicalTrials.gov ID
- NCT06602830
- Acronym / sponsor ID
- 2024-101346-BO-ff
- Keywords
- Airwaymanagement, Laparoscopic surgery, Capnoperitoneum
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 48 participants (actual)
- Lead sponsor
- Universitätsklinikum Hamburg-EppendorfUniversity, hospital or other
- Study start
- 1 Oct 2024 (actual)
- Primary completion
- 3 Feb 2025 (actual)
- Study completion
- 3 Feb 2025 (actual)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
i-gel Plus is a novel supraglottic airway device (SGA). Feasibility of second-generation SGAs in patients undergoing elective laparoscopic surgery has been demonstrated in various studies. During laparoscopic surgery intrabdominal pressure is increased by capnoperitoneum and frequently minute ventilation has to be adopted to counteract hypercapnia, and higher inspiratory peak pressures have to be expected. It is uncertain, however, if the i-gel Plus facilitates appropriate ventilation with low leakage volumes in patients undergoing laparoscopic surgery.
The primary aim of this single-center non-inferiority study is to assess the leak fraction of the i-gel Plus under conditions of capnoperitoneum (with and without Trendelenburg position) and to compare it with baseline conditions. Secondary aims are to assess secondary outcome parameters during capnoperitoneum (with and without Trendelenburg position) and to compare them with baseline conditions.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients undergoing laparoscopic surgery | – | –Measurement of primary and secondary outcome parameters at different time points during the procedure. |
Who may qualify
- Ages
- 18 to 89 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients undergoing elective laparoscopic surgery with i-gel Plus used for airway management
Key inclusion criteria (4 listed)
- Patients scheduling for elective laparoscopic surgery
- Planned airway management using a SGA
- Adult patients (age 18-89 years)
- ASA physical status 1-3
Key exclusion criteria (5 listed)
- Pregnant or breastfeeding women
- Non-fasted patients
- Increased risk of aspiration or other contraindications for supraglottic mask ventilation
- Body mass index (BMI) >35 kg/m2
- Inability to understand or sign informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Leak fraction
Time frame: 3 houres
Ventilation parameter - volume per tidal volume
19 secondary outcomes
Oropharyngeal seal pressure [cm H2O]
Time frame: 3 houres
Leakage volume (ml)
Time frame: 3 houres
Tidal volume (ml)
Time frame: 3 houres
Inspiratory peak pressure (cm H2O)
Time frame: 3 houres
Positive endexpiratory pressure (PEEP) (cm H2O)
Time frame: 3 houres
Intraabdominal pressure under capnoperitoneum [mmHg]
Time frame: 3 houres
Respiratory rate (1/min)
Time frame: 3 houres
Minute ventilation (l/min/kg)
Time frame: 3 houres
Endtidal CO2 [mmHg]
Time frame: 3 houres
Number of insertion attempts
Time frame: 3 houres
Insertion success rate (%)
Time frame: 3 houres
First-attempt insertion success rate (%)
Time frame: 3 houres
Necessity of adjustment maneuvers during the procedure
Time frame: 3 houres
Insertion time (sec)
Time frame: 3 houres
Lowest oxygen saturation (%)
Time frame: 3 houres
Difficulty of insertion
Time frame: 3 houres
Ease of gastric tube insertion
Time frame: 3 houres
Postoperative complications
Time frame: 24 hours postoperatively
Complications at the end of surgery
Time frame: 3 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2025.
Related trials for Airway Management
Not yet recruitingObservational study
LeHeR Maneuver vs Sniffing Position During Video Laryngoscopy in Predicted Difficult Airway
Difficult Airway, Difficult Intubation
Not yet recruitingObservational study
Sniffing Position vs Left Head Rotation (LeHeR) Maneuver for Glottic View During Direct Laryngoscopy
Difficult Intubation, Laryngoscopy
Not yet recruitingPhase 4
Effect of Neuromuscular Blocking Agent Use on Video Laryngeal Mask Airway Insertion
Airway Management, Supraglottic Airway Device Insertion
Not yet recruiting
Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in Children
Airway Management, Anesthesia, General
Not yet recruitingObservational study
Prediction of Difficult Mask Ventilation in Obese Population Undergoing Emergency Surgery
Difficult Airway Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Martin Petzoldt, MD principal investigator
Universitätsklinikum Hamburg-Eppendorf
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Airway Management and Supraglottic Airway, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Leak fraction (time frame: 3 houres). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2025.